Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate.

@article{Jeng2014IncidenceOS,
  title={Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate.},
  author={Karen W Jeng and Howard F. Fine and Harold Matthew Wheatley and Daniel B Roth and Daniel Connors and Jonathan L. Prenner},
  journal={Retina},
  year={2014},
  volume={34 10},
  pages={1990-6}
}
PURPOSE To identify changes in intraocular pressure (IOP) after vitreoretinal surgical procedures in eyes that received either difluprednate ophthalmic emulsion 0.05% (DP) or prednisolone acetate ophthalmic suspension 1% (PA). METHODS A retrospective chart review compared a consecutive series of 100 patients who received DP with 100 patients who received PA after vitreoretinal surgery. Data were collected for a 3-month period from the time of surgery. RESULTS A significantly higher number… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
4 Citations
11 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 11 references

A phase III, open-label, clinical study of difluprednate ophthalmic emulsion (DFBA), 0.05% in the treatment of severe refractory anterior uveitis

  • M Mochizuki, S Ohno, M Usui
  • ARVO Meet Abstr 2007;48:3905
  • 2007

Similar Papers

Loading similar papers…